Abnova Financial Statements From 2010 to 2024
| 4133 Stock | TWD 29.10 0.05 0.17% |
Check Abnova Taiwan financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abnova Taiwan's main balance sheet or income statement drivers, such as , as well as many indicators such as . Abnova financial statements analysis is a perfect complement when working with Abnova Taiwan Valuation or Volatility modules.
Abnova |
Abnova Taiwan Corp Company Current Valuation Analysis
Abnova Taiwan's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Abnova Taiwan Current Valuation | 2.11 B |
Most of Abnova Taiwan's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abnova Taiwan Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Abnova Taiwan Corp has a Current Valuation of 2.11 B. This is 85.33% lower than that of the Life Sciences Tools & Services sector and 54.65% lower than that of the Health Care industry. The current valuation for all Taiwan stocks is 87.33% higher than that of the company.
Abnova Taiwan Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abnova Taiwan's current stock value. Our valuation model uses many indicators to compare Abnova Taiwan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abnova Taiwan competition to find correlations between indicators driving Abnova Taiwan's intrinsic value. More Info.Abnova Taiwan Corp is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Abnova Taiwan Corp is roughly 2.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abnova Taiwan's earnings, one of the primary drivers of an investment's value.About Abnova Taiwan Financial Statements
Abnova Taiwan investors use historical fundamental indicators, such as Abnova Taiwan's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Abnova Taiwan. Please read more on our technical analysis and fundamental analysis pages.
Abnova Corporation manufactures and sells various recombinant proteins and antibodies. Abnova Corporation is headquartered in Taipei, Taiwan. ABNOVA CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abnova Stock Analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.